Roche eyes direct-to-patient sales in U.S. to avoid pharma middlemen

Roche Diagnostics campus facade in Silicon Valley

Michael Vi/iStock Editorial via Getty Images

Roche (OTCQX:RHHBY) (OTCQX:RHHBF) announced Thursday it has begun discussions with the U.S. government to launch direct-to-patient sales as part of an attempt to avoid the influence exerted by pharma middlemen, also known as pharmacy benefit managers, in product pricing.

“Something

Leave a Reply

Your email address will not be published. Required fields are marked *